×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GPCR – structure therapeutics inc. - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GPCR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
01:05 pm
gpcr
Structure Therapeutics (NASDAQ:GPCR) was given a new $50.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
Structure Therapeutics (NASDAQ:GPCR) was given a new $50.00 price target on by analysts at Stifel Nicolaus.
11/28
07:02 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Structure Therapeutics (NASDAQ:GPCR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/24
07:02 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
11/16
10:26 pm
gpcr
BMO Capital Remains Bullish on Structure Therapeutics (GPCR), Cites Upcoming Trial Readouts [Yahoo! Finance]
Low
Report
BMO Capital Remains Bullish on Structure Therapeutics (GPCR), Cites Upcoming Trial Readouts [Yahoo! Finance]
11/6
04:01 pm
gpcr
Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
Low
Report
Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
10/28
10:59 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
10/21
07:28 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
Structure Therapeutics (NASDAQ:GPCR) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
10/3
03:45 pm
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/14
12:07 pm
gpcr
Form SCHEDULE 13G/A Structure Therapeutics Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SCHEDULE 13G/A Structure Therapeutics Filed by: JANUS HENDERSON GROUP PLC
11/14
09:02 am
gpcr
Form SCHEDULE 13G Structure Therapeutics Filed by: Avoro Capital Advisors LLC
Medium
Report
Form SCHEDULE 13G Structure Therapeutics Filed by: Avoro Capital Advisors LLC
11/14
08:15 am
gpcr
Form SCHEDULE 13G/A Structure Therapeutics Filed by: Deep Track Capital, LP
Medium
Report
Form SCHEDULE 13G/A Structure Therapeutics Filed by: Deep Track Capital, LP
11/7
08:18 am
gpcr
Form SCHEDULE 13G/A Structure Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
Low
Report
Form SCHEDULE 13G/A Structure Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/7
08:16 am
gpcr
Form SCHEDULE 13G/A Structure Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
Low
Report
Form SCHEDULE 13G/A Structure Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/6
04:59 pm
gpcr
Form 10-Q Structure Therapeutics For: Sep 30
Low
Report
Form 10-Q Structure Therapeutics For: Sep 30
11/6
04:18 pm
gpcr
Form 8-K Structure Therapeutics For: Nov 06
Low
Report
Form 8-K Structure Therapeutics For: Nov 06
9/22
09:25 pm
gpcr
Form 4 Structure Therapeutics For: Sep 18 Filed by: Coll Crespo Blas
Low
Report
Form 4 Structure Therapeutics For: Sep 18 Filed by: Coll Crespo Blas
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: